Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
David's Bridal Files for Bankruptcy, but Your Order Is Safe
David’s Bridal has filed for bankruptcy protection, the second time for the chain in the past five years.
Stocks Drift Higher as Earnings Season Kicks Into Gear
Wall Street drifted higher Monday to kick off the first full week of earnings reporting season.
US Tax Breaks Lure European Clean Tech Companies as EU Lags
Norwegian battery startup Freyr is planning its next factory in an Atlanta suburb because a new U.S. clean energy law offers generous tax credits for local production.
Morning Alexa Flash Briefings of April 17th
Morning Alexa Flash Briefings
Cheddar Morning News Briefings of April 17th
Cheddar Morning News Briefings
First Test Flight Ahead for SpaceX's Starship Rocket
The company got the OK on Friday from the Federal Aviation Administration. CEO Elon Musk is giving 50-50 odds of Starship reaching orbit.
Breaking Down the Pros and Cons of ChatGPT
Breaking Down the Pros and Cons of ChatGPT
The Week Ahead: Big Bank Earnings, Elon Musk to Speak and March Housing Data
The Week Ahead: Big Bank Earnings, Elon Musk to Speak and March Housing Data
Vertical Farming Startup Babylon CEO Discusses Benefits of Indoor Farming Technology
Vertical farming startup Babylon Micro-Farms recently raised $8 million in a Serie A round. Alexander Oleson, CEO and co-founder of Babylon Micro-Farms, joined Cheddar News to explain his company's mission to help businesses and communities grow their own fresh produce in a sustainable manner.
